Echterhof A, Dharmaraj T, Khosravi A, McBride R, Miesel L, Chia J
JCI Insight. 2024; 9(20).
PMID: 39435664
PMC: 11530120.
DOI: 10.1172/jci.insight.181309.
Kang D, Bagchi D, Chen I
Adv Ther (Weinh). 2024; 7(3).
PMID: 38933919
PMC: 11198966.
DOI: 10.1002/adtp.202300355.
Asar M, Newton-Northup J, Soendergaard M
Viruses. 2024; 16(4).
PMID: 38675913
PMC: 11055145.
DOI: 10.3390/v16040570.
Sahagun D, Zahid M
Biomolecules. 2023; 13(12).
PMID: 38136562
PMC: 10741768.
DOI: 10.3390/biom13121690.
Wong S, Jimenez S, Slavcev R
Microb Cell Fact. 2023; 22(1):124.
PMID: 37430278
PMC: 10334589.
DOI: 10.1186/s12934-023-02135-w.
Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties.
Andre A, Moutinho I, Dias J, Aires-da-Silva F
Front Microbiol. 2022; 13:962124.
PMID: 36225354
PMC: 9549074.
DOI: 10.3389/fmicb.2022.962124.
A Strategy to Select Macrocyclic Peptides Featuring Asymmetric Molecular Scaffolds as Cyclization Units by Phage Display.
Oppewal T, Jansen I, Hekelaar J, Mayer C
J Am Chem Soc. 2022; 144(8):3644-3652.
PMID: 35171585
PMC: 8895403.
DOI: 10.1021/jacs.1c12822.
Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Infections.
Holger D, Kebriaei R, Morrisette T, Lev K, Alexander J, Rybak M
Antibiotics (Basel). 2021; 10(5).
PMID: 34064648
PMC: 8151982.
DOI: 10.3390/antibiotics10050556.
Liver sinusoidal endothelial cells contribute to the uptake and degradation of entero bacterial viruses.
Oie C, Wolfson D, Yasunori T, Dumitriu G, Sorensen K, McCourt P
Sci Rep. 2020; 10(1):898.
PMID: 31965000
PMC: 6972739.
DOI: 10.1038/s41598-020-57652-0.
Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
Dabrowska K, Abedon S
Microbiol Mol Biol Rev. 2019; 83(4).
PMID: 31666296
PMC: 6822990.
DOI: 10.1128/MMBR.00012-19.
Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons.
Sellers D, Tan J, Pineda J, Peeler D, Porubsky V, Olden B
ACS Nano. 2019; 13(10):10961-10971.
PMID: 31589023
PMC: 7651855.
DOI: 10.1021/acsnano.9b01515.
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies.
Sartorius R, DApice L, Prisco A, De Berardinis P
Pharmaceutics. 2019; 11(9).
PMID: 31480551
PMC: 6781307.
DOI: 10.3390/pharmaceutics11090437.
Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.
Dabrowska K
Med Res Rev. 2019; 39(5):2000-2025.
PMID: 30887551
PMC: 6767042.
DOI: 10.1002/med.21572.
Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.
Vitetta L, Vitetta G, Hall S
Front Immunol. 2018; 9:2240.
PMID: 30356736
PMC: 6189397.
DOI: 10.3389/fimmu.2018.02240.
Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting.
Gustafson H, Olshefsky A, Sylvestre M, Sellers D, Pun S
Adv Drug Deliv Rev. 2018; 130:39-49.
PMID: 29964079
PMC: 6512807.
DOI: 10.1016/j.addr.2018.06.015.
Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through Panning.
Bakhshinejad B, Nasiri H
Iran J Pharm Res. 2018; 17(1):396-407.
PMID: 29755570
PMC: 5937109.
Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells.
Lehti T, Pajunen M, Skog M, Finne J
Nat Commun. 2017; 8(1):1915.
PMID: 29203765
PMC: 5715158.
DOI: 10.1038/s41467-017-02057-3.
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
Ferrara F, Staquicini D, Driessen W, DAngelo S, Dobroff A, Barry M
Proc Natl Acad Sci U S A. 2016; 113(45):12786-12791.
PMID: 27791181
PMC: 5111687.
DOI: 10.1073/pnas.1615400113.
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.
Dobroff A, DAngelo S, Eckhardt B, Ferrara F, Staquicini D, Cardo-Vila M
Proc Natl Acad Sci U S A. 2016; 113(45):12780-12785.
PMID: 27791177
PMC: 5111698.
DOI: 10.1073/pnas.1615288113.
Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2.
Muller J, Reichel R, Vogt S, Muller S, Sauerwein W, Brandau W
PLoS One. 2016; 11(10):e0163648.
PMID: 27716771
PMC: 5055303.
DOI: 10.1371/journal.pone.0163648.